Kapitalo Investimentos’s CorMedix CRMD Stock Holding History

Kapitalo Investimentos’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,016	Closed	-$123K	–	85
2025 Q2	$123K	Buy	+10,016	New	+$111K	0.03%	91

Other funds holding CRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kapitalo Investimentos's CRMD Position: Q3 2025 in Review

Kapitalo Investimentos sold out of CorMedix (CRMD) in Q3 2025, closing a stake of 10,016 shares — an estimated $123K sold.

Kapitalo Investimentos first reported a position in CRMD in Q2 2025 and held it in 1 quarter. The position peaked at $123K in Q2 2025. 190 funds tracked by Wall St. Rank hold CRMD as of Q3 2025.

Kapitalo Investimentos reported no remaining CorMedix position as of Q3 2025 after selling out during the quarter.
Kapitalo Investimentos sold 10,016 CorMedix shares in Q3 2025, an estimated $123K.
Kapitalo Investimentos first reported a position in CorMedix in Q2 2025 and held it in 1 quarter.
Kapitalo Investimentos's CorMedix position peaked at $123K in Q2 2025.
190 funds tracked by Wall St. Rank held CorMedix as of Q3 2025.

Based on Kapitalo Investimentos's 13F filing for Q3 2025, filed 3 Nov 2025.